Big Gain For VistaGen Therapeutics, Inc.

Wed, Aug 17, 2022 at 07:05 PM
Big Gain For VistaGen Therapeutics, Inc.

VistaGen Therapeutics, Inc. (VTGN:NASDAQ) rocketted at $0.19, representing a gain of 23.1%. On Wed, Aug 17, 2022, VTGN:NASDAQ hit a New 2-Week High of $0.19. The stock appeared on our News Catalysts scanner on Thu, Aug 11, 2022 at 06:16 PM in the 'INVESTOR UPDATE' category. From Wed, Aug 03, 2022, the stock recorded 40.00% Up Days and 36.36% Green Days

The stock spiked on Thu, Jul 21, 2022 at $1.07 with a volume of 3M+.

About VistaGen Therapeutics, Inc. (VTGN:NASDAQ)

VistaGen Therapeutics Inc is a clinical-stage biopharmaceutical company that develops and commercializes product candidates for patients with central nervous system diseases. Its product AV-101 is currently being evaluated in a Phase 2 monotherapy study.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.